Polyp subtype and SCRC status | p Value* |
---|---|
SSA/P/L (IS) vs HP (IS) | <0.001 |
BSSA/P/L (IS) vs HP (IS) | 0.002 |
SSA/P/L (IS) vs BSSA/P/L (IS) | 0.039 |
All ND-SP-SCRC vs ND-SP | 0.188 |
SSA/P/L-SCRC vs SSA/P/L | 0.718 |
BSSA/P/L-SCRC vs BSSA/P/L | 0.424 |
HP-SCRC vs HP | 0.480 |
SSA/P/L-SCRC vs BSSA/P/L-SCRC | 0.188 |
SSA/P/L-SCRC vs HP-SCRC | <0.001 |
BSSA/P/L-SCRC vs HP-SCRC | 0.040 |
SSA/P/L vs BSSA/P/L | 0.110 |
SSA/P/L vs HP | <0.001 |
BSSA/P/L vs HP | 0.210 |
*p Values from Fisher's exact test.
BSSA/P/L, borderline sessile serrated adenoma/polyp/lesion; HP, hyperplastic polyp; IS, ignoring SCRC status; ND-SP, non-dysplastic serrated polyp; SCRC, synchronous colorectal cancer; SSA/P/L, sessile serrated adenoma/polyp/lesion.